ICMR-NICED proposes research on oral COVID vaccine

Kolkata-based ICMR-NICED has submitted a proposal to the Department of Biotechnology under the Union Ministry of Science and Technology for research on an oral COVID vaccine, a senior official of the institute said on Monday.

The proposed research project will be done in collaboration with a German firm and it has been shortlisted for presentation, she said.

“We have submitted a proposal for research on an oral vaccine. It will be carried out in collaboration with a German firm. Work can be started once it gets selected and funded,” ICMR-NICED Director Shanta Dutta said.

She said it will take around 5-6 years to develop the oral vaccine in a laboratory.

Once the oral vaccine is developed, it will first be tested on animals as is done for all vaccines, Dutta said.

“All stages of developing a vaccine, and phases of clinical trials for safety and immunogenicity will be followed in this case too and the vaccine will be first tested on animals.

“The entire process will take at least five to six years and we can expect the oral vaccine in the market only after that,” she added.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’